Arcadia Biosciences, Inc. (NASDAQ:RKDA – Get Free Report)’s share price crossed below its 50-day moving average during trading on Tuesday . The stock has a 50-day moving average of $0.63 and traded as low as $0.4897. Arcadia Biosciences shares last traded at $0.5037, with a volume of 68,375 shares traded.
Wall Street Analyst Weigh In
Separately, Weiss Ratings lowered shares of Arcadia Biosciences from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Thursday, June 25th. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the stock has a consensus rating of “Sell”.
Get Our Latest Report on Arcadia Biosciences
Arcadia Biosciences Stock Performance
Arcadia Biosciences (NASDAQ:RKDA – Get Free Report) last posted its quarterly earnings data on Thursday, August 13th. The basic materials company reported ($2.09) earnings per share for the quarter, missing the consensus estimate of ($0.56) by ($1.53). Arcadia Biosciences had a negative net margin of 234.53% and a negative return on equity of 183.50%. The company had revenue of $1.44 million during the quarter, compared to analyst estimates of $1.90 million.
About Arcadia Biosciences
Arcadia Biosciences, Inc, founded in 2002 and headquartered in Davis, California, is an agricultural biotechnology company dedicated to developing crops and food ingredients that promote health and sustainability. By harnessing advanced genomics and precision?breeding technologies, Arcadia creates proprietary trait platforms designed to enhance crop performance, nutritional value, and resilience to environmental stressors. The company’s scientific expertise focuses on non-transgenic approaches, enabling the delivery of novel traits without introducing foreign DNA.
Arcadia’s operations span two main segments: Crop Traits and Food Ingredients.
Further Reading
- Five stocks we like better than Arcadia Biosciences
- The Path to $230 Billion: Broadcom Outlines the Next Phase of Its AI Growth Story
- NVIDIA’s Hugging Face Deal Raises a Bigger Question About Its AI Moat Now
- Dropping the Dough: Yum! Brands Strategically Trims the Fat
- These 3 Stock Charts Just Flashed the Dreaded Death Cross Pattern
Receive News & Ratings for Arcadia Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arcadia Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
